HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$11.98
Day range
$10.67 - $12.00
Year range
$4.60 - $14.93
Market cap
199.60M USD
Avg Volume
155.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.84M | -34.39% |
Net income | -7.72M | 44.89% |
Net profit margin | — | — |
Earnings per share | -0.49 | 51.96% |
EBITDA | -8.79M | 34.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.56M | 5.36% |
Total assets | 25.86M | -8.22% |
Total liabilities | 24.23M | -38.65% |
Total equity | 1.64M | — |
Shares outstanding | 18.40M | — |
Price to book | 133.11 | — |
Return on assets | -81.65% | — |
Return on capital | -126.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.72M | 44.89% |
Cash from operations | -6.80M | 22.27% |
Cash from investing | -16.00K | 64.44% |
Cash from financing | 4.86M | 2,042.29% |
Net change in cash | -2.05M | 76.03% |
Free cash flow | -3.02M | 20.65% |
About
Founded
2011
Headquarters
Website
Employees
33
